Cargando…

Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy

SIMPLE SUMMARY: Brain-specific angiogenesis inhibitor 1 (BAI1) is a transmembrane adhesion GPCR protein that plays an important role in many cellular processes and functions. The ability of BAI1 to promote anti-tumor and anti-angiogenic effects has been explored and developed as a treatment option f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Mitra, Bolyard, Chelsea, Lee, Tae Jin, Kaur, Balveen, Yoo, Ji Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303278/
https://www.ncbi.nlm.nih.gov/pubmed/34298774
http://dx.doi.org/10.3390/cancers13143562
_version_ 1783727048543436800
author Nair, Mitra
Bolyard, Chelsea
Lee, Tae Jin
Kaur, Balveen
Yoo, Ji Young
author_facet Nair, Mitra
Bolyard, Chelsea
Lee, Tae Jin
Kaur, Balveen
Yoo, Ji Young
author_sort Nair, Mitra
collection PubMed
description SIMPLE SUMMARY: Brain-specific angiogenesis inhibitor 1 (BAI1) is a transmembrane adhesion GPCR protein that plays an important role in many cellular processes and functions. The ability of BAI1 to promote anti-tumor and anti-angiogenic effects has been explored and developed as a treatment option for several different malignancies. Here, we have detailed a systemic overview of BAI, with a focus on its therapeutic potential for cancer. Due to the recent developments in oncolytic viruses and gene therapeutics towards targeting various types of cancers, our review article is highly relevant to clinical translation. ABSTRACT: Brain-specific angiogenesis inhibitor 1 (BAI1/ADGRB1) is an adhesion G protein-coupled receptor that has been found to play key roles in phagocytosis, inflammation, synaptogenesis, the inhibition of angiogenesis, and myoblast fusion. As the name suggests, it is primarily expressed in the brain, with a high expression in the normal adult and developing brain. Additionally, its expression is reduced in brain cancers, such as glioblastoma (GBM) and peripheral cancers, suggesting that BAI1 is a tumor suppressor gene. Several investigators have demonstrated that the restoration of BAI1 expression in cancer cells results in reduced tumor growth and angiogenesis. Its expression has also been shown to be inversely correlated with tumor progression, neovascularization, and peri-tumoral brain edema. One method of restoring BAI1 expression is by using oncolytic virus (OV) therapy, a strategy which has been tested in various tumor models. Oncolytic herpes simplex viruses engineered to express the secreted fragment of BAI1, called Vasculostatin (Vstat120), have shown potent anti-tumor and anti-angiogenic effects in multiple tumor models. Combining Vstat120-expressing oHSVs with other chemotherapeutic agents has also shown to increase the overall anti-tumor efficacy in both in vitro and in vivo models. In the current review, we describe the structure and function of BAI1 and summarize its application in the context of cancer treatment.
format Online
Article
Text
id pubmed-8303278
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83032782021-07-25 Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy Nair, Mitra Bolyard, Chelsea Lee, Tae Jin Kaur, Balveen Yoo, Ji Young Cancers (Basel) Review SIMPLE SUMMARY: Brain-specific angiogenesis inhibitor 1 (BAI1) is a transmembrane adhesion GPCR protein that plays an important role in many cellular processes and functions. The ability of BAI1 to promote anti-tumor and anti-angiogenic effects has been explored and developed as a treatment option for several different malignancies. Here, we have detailed a systemic overview of BAI, with a focus on its therapeutic potential for cancer. Due to the recent developments in oncolytic viruses and gene therapeutics towards targeting various types of cancers, our review article is highly relevant to clinical translation. ABSTRACT: Brain-specific angiogenesis inhibitor 1 (BAI1/ADGRB1) is an adhesion G protein-coupled receptor that has been found to play key roles in phagocytosis, inflammation, synaptogenesis, the inhibition of angiogenesis, and myoblast fusion. As the name suggests, it is primarily expressed in the brain, with a high expression in the normal adult and developing brain. Additionally, its expression is reduced in brain cancers, such as glioblastoma (GBM) and peripheral cancers, suggesting that BAI1 is a tumor suppressor gene. Several investigators have demonstrated that the restoration of BAI1 expression in cancer cells results in reduced tumor growth and angiogenesis. Its expression has also been shown to be inversely correlated with tumor progression, neovascularization, and peri-tumoral brain edema. One method of restoring BAI1 expression is by using oncolytic virus (OV) therapy, a strategy which has been tested in various tumor models. Oncolytic herpes simplex viruses engineered to express the secreted fragment of BAI1, called Vasculostatin (Vstat120), have shown potent anti-tumor and anti-angiogenic effects in multiple tumor models. Combining Vstat120-expressing oHSVs with other chemotherapeutic agents has also shown to increase the overall anti-tumor efficacy in both in vitro and in vivo models. In the current review, we describe the structure and function of BAI1 and summarize its application in the context of cancer treatment. MDPI 2021-07-16 /pmc/articles/PMC8303278/ /pubmed/34298774 http://dx.doi.org/10.3390/cancers13143562 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nair, Mitra
Bolyard, Chelsea
Lee, Tae Jin
Kaur, Balveen
Yoo, Ji Young
Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
title Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
title_full Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
title_fullStr Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
title_full_unstemmed Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
title_short Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
title_sort therapeutic application of brain-specific angiogenesis inhibitor 1 for cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303278/
https://www.ncbi.nlm.nih.gov/pubmed/34298774
http://dx.doi.org/10.3390/cancers13143562
work_keys_str_mv AT nairmitra therapeuticapplicationofbrainspecificangiogenesisinhibitor1forcancertherapy
AT bolyardchelsea therapeuticapplicationofbrainspecificangiogenesisinhibitor1forcancertherapy
AT leetaejin therapeuticapplicationofbrainspecificangiogenesisinhibitor1forcancertherapy
AT kaurbalveen therapeuticapplicationofbrainspecificangiogenesisinhibitor1forcancertherapy
AT yoojiyoung therapeuticapplicationofbrainspecificangiogenesisinhibitor1forcancertherapy